AJP - Endo Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab (September 2, 2008). doi:10.1152/ajpendo.90558.2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/5/E1009    most recent
90558.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Galgani, J. E
Right arrow Articles by Ravussin, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Galgani, J. E
Right arrow Articles by Ravussin, E.
Submitted on July 2, 2008
Revised on August 13, 2008
Accepted on August 22, 2008

Metabolic Flexibility and Insulin Resistance

Jose E Galgani1, Cedric MORO1, and Eric Ravussin1*

1 Pennington Biomedical Research Center

* To whom correspondence should be addressed. E-mail: ravusse{at}pbrc.edu.

Metabolic flexibility is the capacity for the organism to adapt fuel oxidation to fuel availability. The inability to modify fuel oxidation in response to changes in nutrient availability has been implicated in the accumulation of intramyocellular lipid and insulin resistance. The metabolic flexibility assessed by the ability to switch from fat to carbohydrate oxidation is usually impaired during a hyperinsulinemic clamp in insulin-resistant subjects; however, this "metabolic inflexibility" is mostly the consequence of impaired cellular glucose uptake. Indeed, after controlling for insulin-stimulated glucose disposal rate (amount of glucose available for oxidation), metabolic flexibility is not altered in obesity regardless of the presence of type 2 diabetes. To understand how intramyocellular lipids accumulate and cause insulin resistance, the assessment of metabolic flexibility to high-fat diets is more relevant than metabolic flexibility during a hyperinsulinemic clamp. An impaired capacity to up-regulate muscle lipid oxidation in face of high lipid supply may lead to increased muscle fat accumulation and insulin resistance. Surprisingly, only very few studies have investigated the response to high-fat diets. This review, we discuss the role of glucose disposal rate, adipose tissue lipid storage and mitochondrial function on metabolic flexibility. Additionally, we emphasize the bias of using the change in respiratory quotient to calculate metabolic flexibility and propose novel approaches to assess metabolic flexibility. Based on current evidence, one cannot conclude that impaired metabolic flexibility is responsible for the accumulation of intramyocellular lipid and insulin resistance. We propose to study metabolic flexibility in response to high-fat diets in individuals having contrasting degree of insulin sensitivity and/or mitochondrial characteristics.




This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
I. Dostalova, T. Roubicek, M. Bartlova, M. Mraz, Z. Lacinova, D. Haluzikova, P. Kavalkova, M. Matoulek, M. Kasalicky, and M. Haluzik
Increased serum concentrations of macrophage inhibitory cytokine-1 in patients with obesity and type 2 diabetes mellitus: the influence of very low calorie diet
Eur. J. Endocrinol., September 1, 2009; 161(3): 397 - 404.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.